Detecting PSA-positive Cells in Prostate Cancer Patients
Author Information
Author(s): EJ Fadlon, RC Rees, C McIntyre, RM Sharrard, J Lawry, FC Hamdy
Primary Institution: Institute for Cancer Studies, University of Sheffield Medical School
Hypothesis
The study aims to determine whether circulating PSA-positive cells in prostate cancer patients represent tumor cells or other cell types.
Conclusion
The majority of PSA-positive cells detected in the blood of prostate cancer patients do not express PSA mRNA, suggesting they are not tumor cells.
Supporting Evidence
- 75% of prostate cancer patients had circulating PSA-positive cells detected by flow cytometry.
- Only 11.1% of those patients expressed PSA mRNA by RT-PCR.
- The absence of PSA mRNA in most samples suggests that PSA-positive cells are not tumor cells.
Takeaway
Doctors looked for special cells in the blood of men with prostate cancer to see if they were cancer cells, but most of them weren't.
Methodology
The study used flow cytometry and reverse transcription polymerase chain reaction (RT-PCR) to analyze blood samples from prostate cancer patients and controls.
Limitations
The study had a small sample size and did not fully characterize the phenotype of the detected PSA-positive cells.
Participant Demographics
The study included 12 men with newly diagnosed and untreated prostate cancer and 5 control subjects (3 men with benign prostatic hyperplasia and 2 healthy women).
Want to read the original?
Access the complete publication on the publisher's website